Condition: Tension Type Headache · Sponsor: Helse Nord-Trøndelag HF
The purpose of this study is to test a therapist-independent home-based smartphone app-based biofeedback treatment in adults with tension type headache. The aim of the study is to assess the safety and performance of the Cerebri-TTH biofeedback device as a preventive treatment in adults with frequent and chronic tension type headache. The primary endpoint of the study is the change in the mean Area-Under-the-headache-Curve (AUC) from baseline to the last 28-day period during the treatment phase, in the treatment group as compared to the placebo group.
This description comes directly from the study's public registry record.
Tore Wergeland Meisingset, MD, PhD, Assc. Prof · +4747358725 · tore.w.meisingset@ntnu.no
Kristina Devik, MD · +4798833255 · kristina.devik@helse-nordtrondelag.no
Always discuss trial participation with your own doctor first.
| Namsos Hospital | Namsos, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07136740